The Human Medicines Regulations 2012
3 Manufacture and distribution of medicinal products and active substances
Conditions for holding a manufacturer's licence
- 36Conditions for manufacturer's licence
- 37Manufacturing and assembly
- 37aManufacturing and assembly of MM medicinal products: additional requirements
- 37bManufacturing and assembly of POC medicinal products: additional requirements
- 38Imports from states other than EEA States / countries other than approved countries for import
- 39Further requirements for manufacturer's licence
- 40Obligation to provide information relating to control methods
- 41Requirements as to qualified persons
Conditions for holding a wholesale dealer's licence
- 42Conditions for wholesale dealer's licence
- 43Obligations of licence holder
- 43zaObligations of licence holder in Great Britain supplying listed NIMAR products to Northern Ireland
- 43aRequirement for wholesale dealers to decommission the unique identifier
- 44Requirement for wholesale dealers to deal only with specified persons
- 45Requirement as to responsible persons
- 45aaRequirement as to responsible persons where licence holder imports from an approved country for import
- 45abRegister for responsible persons (import)
- 17Manufacturing of medicinal products
- 17aManufacturing of MM medicinal products
- 17bManufacturing of POC medicinal products
- 18Wholesale dealing in medicinal products
- 18aApproved country for import
- 19Exemptions from requirement for wholesale dealer's licence
- 20Mixing of medicines
- 21Application for manufacturer's or wholesale dealer's licence
- 22Factors relevant to determination of application for manufacturer's or wholesale dealer's licence
- 23Grant or refusal of licence
- 24Standard provisions of licences
- 25Duration of licence
- 26General power to suspend, revoke or vary licences
- 27Procedure where licensing authority proposes to suspend, revoke or vary licence
- 27aEffect of suspension or variation relating to modular unit or POC site
- 28Suspension of licence in cases of urgency
- 29Variation of licence on the application of the holder
- 29aVariation of MM master file
- 29bVariation of POC master file
- 30Provision of information
- 45aBrokering in medicinal products
- 45bApplication for brokering registration
- 45cProcedure for determining an application for broker’s registration
- 45dGrant or refusal of broker’s registration
- 45eCriteria of broker’s registration
- 45fProvision of information
- 45gPower to suspend or vary a broker’s registration or remove a broker from the register
- 45hProcedure where licensing authority proposes to suspend or vary a broker’s registration or remove a broker
- 45iSuspension of a broker registration in cases of urgency
- 45jVariation of a broker’s registration on the application of the broker
- 45kOffences: breach of regulations and false information
- 45lPenalties
- 45mCriteria for importation, manufacture or distribution of active substances
- 45nRegistration in relation to active substances
- 45oRequirements for registration as an importer, manufacturer or distributor of an active substance
- 45pProvision of information
- 45qPower to suspend or vary or remove an active substance registration
- 45rProcedure where licensing authority proposes to suspend or vary an active substance registration or remove
- 45sSuspension of an active substance registration in cases of urgency
- 45tVariation of an active substance registration on an application from the registered person
- 45uOffences: breach of regulations and false information
- 45vPenalties
Source: legislation.gov.uk (The National Archives), UK legislation with its point-in-time versions. Official publication. Reuse: Open Government Licence v3.0.